Diltzac

Angina Pectoris, Variant, Atrial Fibrillation, Proteinuria + 11 more
Treatment
4 FDA approvals
20 Active Studies for Diltzac

What is Diltzac

DiltiazemThe Generic name of this drug
Treatment SummaryDiltiazem is a medication used to treat high blood pressure and other cardiovascular conditions like chronic angina and atrial fibrillation. It is classified as a non-dihydropyridine calcium channel blocker, meaning it inhibits the flow of calcium into the heart and blood vessels. Diltiazem is available as an extended-release tablet or intravenous injection and is sold under the brand names Cardizem and Tiazac. It can also be used for off-label treatments such as migraine prevention and rest-related cramps.
Cardizemis the brand name
image of different drug pills on a surface
Diltzac Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Cardizem
Diltiazem
1982
656

Approved as Treatment by the FDA

Diltiazem, commonly known as Cardizem, is approved by the FDA for 4 uses which include Chronic Stable Angina Pectoris and Hypertensive disease .
Chronic Stable Angina Pectoris
Helps manage Chronic Stable Angina Pectoris
Hypertensive disease
Helps manage High Blood Pressure (Hypertension)
Coronary Artery Vasospasm
Helps manage Coronary Artery Vasospasm
Anginal Pain
Helps manage Anginal Pain

Effectiveness

How Diltzac Affects PatientsDiltiazem is a medication used to reduce blood pressure and relax the blood vessels. It works by blocking calcium in the muscles of the heart and blood vessels to decrease the force and speed of the heart, resulting in lower blood pressure. This drug is most effective in those with higher blood pressure, with a drop of up to 8.6 mmHg after taking doses of 540 mg or higher. It has also been found to increase exercise tolerance in people with chronic stable angina. Studies have also found that using diltiazem can reduce the risk of stroke in hypertensive patients by 25%.
How Diltzac works in the bodyDiltiazem works by blocking the slow calcium channels that allow calcium to flow into the cells of your heart and blood vessels. This decreases the amount of calcium in your cells, which relaxes your heart and blood vessels and lowers your blood pressure. It also helps to slow down your heart rate, reducing the oxygen demand of your heart. As a result, this reduces the pain of chronic stable angina and improves your exercise tolerance.

When to interrupt dosage

The suggested dosage of Diltzac is contingent upon the determined condition, such as prophylaxis of migraine headaches, Fissure;Anal and Anginal Pain. Dosage is additionally reliant on the method of delivery outlined in the table beneath.
Condition
Dosage
Administration
Proteinuria
, 120.0 mg, 180.0 mg, 240.0 mg, 300.0 mg, 360.0 mg, 420.0 mg, 100.0 mg, 60.0 mg, 90.0 mg, 30.0 mg, 5.0 mg/mL, 1.0 mg/mL, 0.83 mg/mL
, Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for solution - Intravenous, Intravenous, Capsule, coated, extended release, Capsule, coated, extended release - Oral, Injection, Injection - Intravenous, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Injection, solution, Injection, solution - Intravenous, Tablet, coated, Tablet, coated - Oral, Solution, Solution - Intravenous, Liquid, Liquid - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous
Pulmonary Hypertension
, 120.0 mg, 180.0 mg, 240.0 mg, 300.0 mg, 360.0 mg, 420.0 mg, 100.0 mg, 60.0 mg, 90.0 mg, 30.0 mg, 5.0 mg/mL, 1.0 mg/mL, 0.83 mg/mL
, Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for solution - Intravenous, Intravenous, Capsule, coated, extended release, Capsule, coated, extended release - Oral, Injection, Injection - Intravenous, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Injection, solution, Injection, solution - Intravenous, Tablet, coated, Tablet, coated - Oral, Solution, Solution - Intravenous, Liquid, Liquid - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous
Anginal Pain
, 120.0 mg, 180.0 mg, 240.0 mg, 300.0 mg, 360.0 mg, 420.0 mg, 100.0 mg, 60.0 mg, 90.0 mg, 30.0 mg, 5.0 mg/mL, 1.0 mg/mL, 0.83 mg/mL
, Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for solution - Intravenous, Intravenous, Capsule, coated, extended release, Capsule, coated, extended release - Oral, Injection, Injection - Intravenous, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Injection, solution, Injection, solution - Intravenous, Tablet, coated, Tablet, coated - Oral, Solution, Solution - Intravenous, Liquid, Liquid - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous
Atrial Fibrillation
, 120.0 mg, 180.0 mg, 240.0 mg, 300.0 mg, 360.0 mg, 420.0 mg, 100.0 mg, 60.0 mg, 90.0 mg, 30.0 mg, 5.0 mg/mL, 1.0 mg/mL, 0.83 mg/mL
, Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for solution - Intravenous, Intravenous, Capsule, coated, extended release, Capsule, coated, extended release - Oral, Injection, Injection - Intravenous, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Injection, solution, Injection, solution - Intravenous, Tablet, coated, Tablet, coated - Oral, Solution, Solution - Intravenous, Liquid, Liquid - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous
prophylaxis of migraine headaches
, 120.0 mg, 180.0 mg, 240.0 mg, 300.0 mg, 360.0 mg, 420.0 mg, 100.0 mg, 60.0 mg, 90.0 mg, 30.0 mg, 5.0 mg/mL, 1.0 mg/mL, 0.83 mg/mL
, Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for solution - Intravenous, Intravenous, Capsule, coated, extended release, Capsule, coated, extended release - Oral, Injection, Injection - Intravenous, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Injection, solution, Injection, solution - Intravenous, Tablet, coated, Tablet, coated - Oral, Solution, Solution - Intravenous, Liquid, Liquid - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous
Diabetic Neuropathy
, 120.0 mg, 180.0 mg, 240.0 mg, 300.0 mg, 360.0 mg, 420.0 mg, 100.0 mg, 60.0 mg, 90.0 mg, 30.0 mg, 5.0 mg/mL, 1.0 mg/mL, 0.83 mg/mL
, Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for solution - Intravenous, Intravenous, Capsule, coated, extended release, Capsule, coated, extended release - Oral, Injection, Injection - Intravenous, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Injection, solution, Injection, solution - Intravenous, Tablet, coated, Tablet, coated - Oral, Solution, Solution - Intravenous, Liquid, Liquid - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous
Coronary Artery Vasospasm
, 120.0 mg, 180.0 mg, 240.0 mg, 300.0 mg, 360.0 mg, 420.0 mg, 100.0 mg, 60.0 mg, 90.0 mg, 30.0 mg, 5.0 mg/mL, 1.0 mg/mL, 0.83 mg/mL
, Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for solution - Intravenous, Intravenous, Capsule, coated, extended release, Capsule, coated, extended release - Oral, Injection, Injection - Intravenous, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Injection, solution, Injection, solution - Intravenous, Tablet, coated, Tablet, coated - Oral, Solution, Solution - Intravenous, Liquid, Liquid - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous
Hypertensive disease
, 120.0 mg, 180.0 mg, 240.0 mg, 300.0 mg, 360.0 mg, 420.0 mg, 100.0 mg, 60.0 mg, 90.0 mg, 30.0 mg, 5.0 mg/mL, 1.0 mg/mL, 0.83 mg/mL
, Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for solution - Intravenous, Intravenous, Capsule, coated, extended release, Capsule, coated, extended release - Oral, Injection, Injection - Intravenous, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Injection, solution, Injection, solution - Intravenous, Tablet, coated, Tablet, coated - Oral, Solution, Solution - Intravenous, Liquid, Liquid - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous
Chronic Stable Angina Pectoris
, 120.0 mg, 180.0 mg, 240.0 mg, 300.0 mg, 360.0 mg, 420.0 mg, 100.0 mg, 60.0 mg, 90.0 mg, 30.0 mg, 5.0 mg/mL, 1.0 mg/mL, 0.83 mg/mL
, Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for solution - Intravenous, Intravenous, Capsule, coated, extended release, Capsule, coated, extended release - Oral, Injection, Injection - Intravenous, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Injection, solution, Injection, solution - Intravenous, Tablet, coated, Tablet, coated - Oral, Solution, Solution - Intravenous, Liquid, Liquid - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous
Dilated Cardiomyopathies, Idiopathic
, 120.0 mg, 180.0 mg, 240.0 mg, 300.0 mg, 360.0 mg, 420.0 mg, 100.0 mg, 60.0 mg, 90.0 mg, 30.0 mg, 5.0 mg/mL, 1.0 mg/mL, 0.83 mg/mL
, Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for solution - Intravenous, Intravenous, Capsule, coated, extended release, Capsule, coated, extended release - Oral, Injection, Injection - Intravenous, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Injection, solution, Injection, solution - Intravenous, Tablet, coated, Tablet, coated - Oral, Solution, Solution - Intravenous, Liquid, Liquid - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous
Paroxysmal Supraventricular Tachycardia (PSVT)
, 120.0 mg, 180.0 mg, 240.0 mg, 300.0 mg, 360.0 mg, 420.0 mg, 100.0 mg, 60.0 mg, 90.0 mg, 30.0 mg, 5.0 mg/mL, 1.0 mg/mL, 0.83 mg/mL
, Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for solution - Intravenous, Intravenous, Capsule, coated, extended release, Capsule, coated, extended release - Oral, Injection, Injection - Intravenous, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Injection, solution, Injection, solution - Intravenous, Tablet, coated, Tablet, coated - Oral, Solution, Solution - Intravenous, Liquid, Liquid - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous
Angina Pectoris, Variant
, 120.0 mg, 180.0 mg, 240.0 mg, 300.0 mg, 360.0 mg, 420.0 mg, 100.0 mg, 60.0 mg, 90.0 mg, 30.0 mg, 5.0 mg/mL, 1.0 mg/mL, 0.83 mg/mL
, Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for solution - Intravenous, Intravenous, Capsule, coated, extended release, Capsule, coated, extended release - Oral, Injection, Injection - Intravenous, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Injection, solution, Injection, solution - Intravenous, Tablet, coated, Tablet, coated - Oral, Solution, Solution - Intravenous, Liquid, Liquid - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous
Fissure;Anal
, 120.0 mg, 180.0 mg, 240.0 mg, 300.0 mg, 360.0 mg, 420.0 mg, 100.0 mg, 60.0 mg, 90.0 mg, 30.0 mg, 5.0 mg/mL, 1.0 mg/mL, 0.83 mg/mL
, Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for solution - Intravenous, Intravenous, Capsule, coated, extended release, Capsule, coated, extended release - Oral, Injection, Injection - Intravenous, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Injection, solution, Injection, solution - Intravenous, Tablet, coated, Tablet, coated - Oral, Solution, Solution - Intravenous, Liquid, Liquid - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous
leg cramps
, 120.0 mg, 180.0 mg, 240.0 mg, 300.0 mg, 360.0 mg, 420.0 mg, 100.0 mg, 60.0 mg, 90.0 mg, 30.0 mg, 5.0 mg/mL, 1.0 mg/mL, 0.83 mg/mL
, Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for solution - Intravenous, Intravenous, Capsule, coated, extended release, Capsule, coated, extended release - Oral, Injection, Injection - Intravenous, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Injection, solution, Injection, solution - Intravenous, Tablet, coated, Tablet, coated - Oral, Solution, Solution - Intravenous, Liquid, Liquid - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous

Warnings

Diltzac has ten contraindications and should not be employed in unison with the conditions laid out in the following table.Diltzac Contraindications
Condition
Risk Level
Notes
Heart Attack
Do Not Combine
accessory bypass tract
Do Not Combine
accessory bypass tract
Do Not Combine
absence of a functioning ventricular pacemaker
Do Not Combine
Ventricular Tachycardia
Do Not Combine
absence of a functioning ventricular pacemaker
Do Not Combine
third degree AV block
Do Not Combine
Pulmonary Congestion
Do Not Combine
Shock, Cardiogenic
Do Not Combine
Hypotension
Do Not Combine
There are 20 known major drug interactions with Diltzac.
Common Diltzac Drug Interactions
Drug Name
Risk Level
Description
Abemaciclib
Major
The metabolism of Abemaciclib can be decreased when combined with Diltiazem.
Acalabrutinib
Major
The metabolism of Acalabrutinib can be decreased when combined with Diltiazem.
Alectinib
Major
The metabolism of Alectinib can be decreased when combined with Diltiazem.
Alfentanil
Major
The metabolism of Alfentanil can be decreased when combined with Diltiazem.
Amifostine
Major
Diltiazem may increase the hypotensive activities of Amifostine.
Diltzac Toxicity & Overdose RiskDiltiazem can be toxic if taken in high doses. The toxic dose for mice is between 415 to 740mg/kg when taken orally, and 560 to 810 mg/kg when taken by injection. In dogs, the lethal dose is greater than 50 mg/kg, and in monkeys, 360mg/kg proved to be fatal. People who overdose on diltiazem may experience a slow heartbeat, low blood pressure, heart blockage, or heart failure that can lead to dizziness, lightheadedness, and fatigue. Treatment should depend on the severity of the symptoms and may include atropine, isop
image of a doctor in a lab doing drug, clinical research

Diltzac Novel Uses: Which Conditions Have a Clinical Trial Featuring Diltzac?

228 clinical trials are presently being conducted to investigate the potential of Diltzac to treat Atrial Fibrillation, Coronary Artery Spasm and Paroxysmal Supraventricular Tachycardia (PSVT).
Condition
Clinical Trials
Trial Phases
Pulmonary Hypertension
23 Actively Recruiting
Phase 2, Phase 3, Phase 1, Phase 4, Not Applicable, Early Phase 1
Atrial Fibrillation
151 Actively Recruiting
Not Applicable, Phase 2, Phase 4, Phase 3, Phase 1, Early Phase 1
Paroxysmal Supraventricular Tachycardia (PSVT)
2 Actively Recruiting
Phase 3, Phase 2
Anginal Pain
2 Actively Recruiting
Not Applicable, Phase 4
Chronic Stable Angina Pectoris
1 Actively Recruiting
Not Applicable
prophylaxis of migraine headaches
0 Actively Recruiting
Dilated Cardiomyopathies, Idiopathic
1 Actively Recruiting
Not Applicable
Coronary Artery Vasospasm
0 Actively Recruiting
Fissure;Anal
0 Actively Recruiting
Angina Pectoris, Variant
0 Actively Recruiting
Hypertensive disease
18 Actively Recruiting
Not Applicable, Phase 1, Phase 2, Phase 3
Diabetic Neuropathy
21 Actively Recruiting
Phase 2, Not Applicable, Phase 1
Proteinuria
5 Actively Recruiting
Phase 2, Phase 3, Phase 4
leg cramps
0 Actively Recruiting

Diltzac Reviews: What are patients saying about Diltzac?

5Patient Review
2/18/2022
Diltzac for Ventricular Rate Control in Atrial Fibrillation
Diltiazem is the only medication that has ever helped my heart with Atrial Fibrillation. I'm so thankful that my cardiologist prescribed this life-changing medication to me. It's been two years since I started taking it and it has completely changed my life for the better.
5Patient Review
2/18/2022
Diltzac for Ventricular Rate Control in Atrial Fibrillation
Diltiazem is the only medication that has ever helped my heart with atrial fibrillation. I am extremely grateful to my cardiologist for prescribing this unbelievable good medication for my heart. After 6 weeks of taking it, it changed my life, everything, making my heart to beat normally. It is already 2 years I am taking it . All my gratitude to the scientists, my cardiologist, for giving me back my life!
5Patient Review
5/30/2019
Diltzac for Supraventricular Cardiac Arrhythmia
I haven't had any issues with this treatment other than feeling a little tired.
5Patient Review
5/30/2019
Diltzac for Supraventricular Cardiac Arrhythmia
I've been using this medication with few issues. The only downside is that I sometimes feel tired.
4Patient Review
12/28/2018
Diltzac for Ventricular Rate Control in Atrial Fibrillation
It worked great for me, but I had to stop taking it last year due to changes in my insurance. Almost immediately after stopping the medication, my heart rate issues started up again. But as soon as I started taking the medication again, everything was back to normal.
4Patient Review
12/28/2018
Diltzac for Ventricular Rate Control in Atrial Fibrillation
Insurance problems led me to stop taking this, and soon after I started having heart rate issues again. However, as soon as I restarted the medication, those effects vanished.
3.7Patient Review
11/30/2018
Diltzac for High Blood Pressure
I occasionally feel like there's something crawling under my skin, but this treatment has been helping.
3.7Patient Review
11/30/2018
Diltzac for High Blood Pressure
Sometimes I feel like there's something crawling under my skin.
2.7Patient Review
8/21/2020
Diltzac for High Blood Pressure
While this drug did help to control my blood pressure and arrhythmia, it was not as effective as beta blockers. When the dosage was increased, I started having migraines on a daily basis which led me to discontinue use of the medication.
2.7Patient Review
8/21/2020
Diltzac for High Blood Pressure
My blood pressure and arrhythmia weren't as well controlled on this medication as they were on beta blockers. When my dosage was increased, I started having migraines every day, so I had to stop taking the drug.
2.7Patient Review
11/19/2020
Diltzac for High Blood Pressure
I saw a decrease in my blood pressure after taking this medication, though it is still higher than I'd like. However, I've also developed new problems since starting to take it such as a lump in my rectum and joint pain.
2.7Patient Review
12/15/2018
Diltzac for Supraventricular Cardiac Arrhythmia
I unfortunately found this treatment made me very drowsy.
2.7Patient Review
11/19/2020
Diltzac for High Blood Pressure
I take 120mg once a day as directed. While my blood pressure has lowered since starting the medication, it is still high. However, I have also developed a number of new and unpleasant side effects, including but not limited to: a lump in my rectum, dry stools, lower back pain, and joint pain.
2.7Patient Review
12/15/2018
Diltzac for Supraventricular Cardiac Arrhythmia
I find this medication makes me very drowsy.
2.3Patient Review
5/19/2019
Diltzac for High Blood Pressure
I didn't have a great experience with this medication. After taking it for just two days, I felt really weak and shaky. All I wanted to do was lay down; it made me feel so lousy.
2.3Patient Review
3/23/2022
Diltzac for Ventricular Rate Control in Atrial Fibrillation
I experienced a lot of the listed side effects, which were really unpleasant. The worst were fatigue, chest tightness, difficulty swallowing, and swelling in my extremities.
2.3Patient Review
5/19/2019
Diltzac for High Blood Pressure
I took this medication for two days and found that my legs felt very weak, like rubber. I also had the shakes and felt awful in general. All I wanted to do was lay down; I felt so terrible!
2.3Patient Review
3/23/2022
Diltzac for Ventricular Rate Control in Atrial Fibrillation
I experienced a lot of the listed side effects, which were really unpleasant. The worst ones for me were fatigue, chest tightness, trouble swallowing/swollen glands in neck, itching, and swelling in hands and feet.
2Patient Review
1/23/2019
Diltzac for High Blood Pressure
This treatment did nothing to help regulate my blood pressure or heart rate.
2Patient Review
1/23/2019
Diltzac for High Blood Pressure
I was really disappointed with this treatment. It did nothing to lower my blood pressure or heart rate, even though that's what it's supposed to do.
1.7Patient Review
10/22/2021
Diltzac for High Blood Pressure
I'm 66 years old, and I started feeling really down and depressed. My blood pressure was high, and I felt lightheaded all the time. After taking this medication, my symptoms only got worse. I won't be taking these tablets anymore.
1.7Patient Review
10/22/2021
Diltzac for High Blood Pressure
I have been feeling quite down since starting this medication. I'm 66 and I feel like I'm going through menopause with all the mood swings and irritability. My blood pressure hasn't gone down either, and I've been feeling very lightheaded. No more tablets for me.
1.3Patient Review
10/2/2022
Diltzac for Ventricular Rate Control in Atrial Fibrillation
After getting a cardioversion for afib, I was prescribed Cardizem (diltiazem). However, after only nine days of taking the medication, I stopped because it was having negative effects on my heart rate and blood pressure. It made me incredibly tired to the point where standing was difficult, as well as lightheaded and shaky. The next day after quitting the medication, I felt much better.
1.3Patient Review
3/25/2019
Diltzac for High Blood Pressure
The dosage of 120 mg caused my blood pressure to go up by 30 units. I experienced horrible side effects like jitters and hypersensitivity. I couldn't even drive!
1.3Patient Review
10/2/2022
Diltzac for Ventricular Rate Control in Atrial Fibrillation
I was prescribed Cardizem after getting cardioversion for afib. I took it for 9 days, but sometimes after 3 hours of taking the medication, my heart rate and blood pressure would go up instead of down. I also felt extremely tired, lightheaded, and shaky, so I decided to stop taking it. The next day after quitting Cardizem, I felt much better.
1.3Patient Review
3/25/2019
Diltzac for High Blood Pressure
I had a really bad experience with this drug. I took one 120 mg dose and my blood pressure shot up 30 units. I was incredibly jittery and hyperactive to the point where driving was impossible.
1Patient Review
1/8/2020
Diltzac for High Blood Pressure
After taking this medication for over a year, I started experiencing pain in my left shoulder, hip, and thigh. I also became lethargic and very tired. I got a rash and sun spots on my face. I stopped taking the medication to see if all these symptoms would go away and they did - thank goodness! This medication also did not help lower my blood pressure.
1Patient Review
11/22/2019
Diltzac for High Blood Pressure
I took this for a few days to see if it would help lower my blood pressure. Not only did it not work, but I experienced several side effects like coughing, weakness and fatigue, erectile dysfunction, paranoia and depression. Avoid this drug if you can.
1Patient Review
1/8/2020
Diltzac for High Blood Pressure
I took this for well over a year before I started noticing some serious side effects. Pain in my left shoulder and hip, as well as fatigue and a rash all developed. Once I stopped taking the medication, all of these symptoms went away - which is great! However, it also didn't do anything to help lower my blood pressure.
1Patient Review
11/22/2019
Diltzac for High Blood Pressure
I tried this for a few days to see if it would help with my blood pressure. Not only was it ineffective, but the side effects were awful. Coughing, weakness, fatigue, and impotence are just a few of the problems I experienced while taking this medication. Additionally, I felt incredibly paranoid and depressed. Do yourself a favor and avoid this drug at all cost.
1Patient Review
6/13/2022
Diltzac for High Blood Pressure
I was prescribed this for my blood pressure, as I also have Raynauds syndrome. However, after only thirteen days of taking the medication, I broke out in a terrible itchy rash all over my body. My glands were swollen and I felt like my throat was closing up. This prompted a trip to the ER where they confirmed that the rash was indeed related to the medication. I stopped taking the meds immediately and went back to my old prescription. The doctor said that the rash could take up to two weeks to clear up; however, it is by far the worst rash I have ever experienced.
1Patient Review
6/13/2022
Diltzac for High Blood Pressure
I was put on this medication by my doctor in an effort to help with my Raynaud's Syndrome. However, after only thirteen days of taking the prescribed dosage, I broke out in a terribly itchy rash that covered my entire body. In addition, I also experienced swollen glands and felt like my throat was closing up. This prompted a trip to the ER where they informed me that the rash was likely caused by the medication. Needless to say, I stopped taking the meds and went back to my old prescription. The rash could take up two weeks to clear up; however, even then, it may be worse than anything I
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about diltzac

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Tiadylt the same as diltiazem?

"Tiadylt (diltiazem hydrochloride) inhibits the influx of calcium ions into cells (slow channel blocker)."

Answered by AI

What is the purpose of diltiazem?

"Diltiazem helps to prevent future heart disease, heart attacks and strokes in people with high blood pressure. It can also be used to prevent chest pain caused by angina and to help heal anal fissures."

Answered by AI

What are the side effects of taking diltiazem?

"The following are symptoms of the flu: dizziness or lightheadedness, flushing, headache, weakness, slow heartbeat, vomiting, diarrhea, constipation."

Answered by AI

Is it better to take diltiazem in the morning or at night?

"The traditional way of taking anti-ischemic medication in the morning may not be as effective as taking it before bedtime. This is because there is an increased risk of myocardial ischemia in the morning hours."

Answered by AI

Clinical Trials for Diltzac

Have you considered Diltzac clinical trials? We made a collection of clinical trials featuring Diltzac, we think they might fit your search criteria.
Have you considered Diltzac clinical trials? We made a collection of clinical trials featuring Diltzac, we think they might fit your search criteria.
Have you considered Diltzac clinical trials? We made a collection of clinical trials featuring Diltzac, we think they might fit your search criteria.